All high-flux membranes are equal but some high-flux membranes are less equal than others.

6. Lameire N, Peeters P, Vanholder R et al. Peritoneal dialysis in Europe: an analysis of its rise and fall. Blood Purif 2006; 24: 107–114 7. Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int 2000; 20: 375–383 8. Fenton SS, Schaubel DE, Desmeules M et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997; 30: 334–342 9. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002; 17: 112–117 10. Van Biesen W, Vanholder RC, Veys N et al. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000; 11: 116–125 11. Korevaar JC, Feith GW, Dekker FW et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64: 2222–2228 12. Baboolal K, McEwan P, Sondhi S et al. The cost of renal dialysis in a UK setting—a multicentre study. Nephrol Dial Transplant 2008 13. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies—an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999; 14(Suppl 6): 31–41 14. Shih YC, Guo A, Just PM et al. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int 2005; 68: 319–329 15. Salonen T, Reina T, Oksa H et al. Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis. Int Urol Nephrol 2007; 39: 289–298 16. NBVN jaarverslag 2003. www.nbvn.be, 2008 17. Pulliam J, Hakim R, Lazarus M. Peritoneal dialysis in large dialysis chains. Perit Dial Int 2006; 26: 435–437 18. Curtis BM, Ravani P, Malberti F et al. The shortand long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005; 20: 147–154 19. Goovaerts T, Jadoul M, Goffin E. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy. Nephrol Dial Transplant 2005; 20: 1842–1847 20. Marron B, Martinez Ocana JC, Salgueira M et al. Analysis of patient flow into dialysis: role of education in choice of dialysis modality. Perit Dial Int 2005; 25(Suppl 3): S56–S59 21. Mehrotra R, Marsh D, Vonesh E et al. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int 2005; 68: 378–390 22. Rubin HR, Fink NE, Plantinga LC et al. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004; 291: 697–703 3. Jassal SV, Krishna G, Mallick NP et al. Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study. Nephrol Dial Transplant 2002; 17: 474–477 24. Verger C, Duman M, Durand PY et al. Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients. An analysis of data from the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant 2007; 22: 1218–1223 25. Van BW, Dequidt C, Vijt D et al. Analysis of the reasons for transfers between hemodialysis and peritoneal dialysis and their effect on survivals. Adv Perit Dial 1998; 14: 90–94 26. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307–1320 27. Huisman RM, Nieuwenhuizen MG, Th de CF. Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in The Netherlands. Nephrol Dial Transplant 2002; 17: 1655– 1660 28. Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948–2957 29. Wilkie ME, Plant MJ, Edwards L et al. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17: 84–87